Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission [2]

Blood

Volumn 97, Issue 11, 2001, Pages 3669-3671

  Blaise, Didier ^a   Maraninchi, Dominique ^a   Michallet, Mauricette ^a   Reiffers, Josy ^a   Jouet, Jean Pierre ^a   Milpied, Noël ^a   Devergie, Agnes ^a   Attal, Michel ^a   Sotto, Jean Jacques ^a   Kuentz, Mathieu ^a   Ifrah, Norbert ^a   Dauriac, Charles ^a   Bordigoni, Pierre ^a   Gratecos, Nicole ^a   Guilhot, François ^a   Guyotat, Denis ^a   Gluckman, Eliane ^a   Vernant, Jean Paul ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ACUTE MYELOBLASTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; KAPLAN MEIER METHOD; LETTER; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; WHOLE BODY RADIATION;

EID: 0035383786     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3669     Document Type: Letter

References (8)

1. Blaise D, Maraninchi D, Archimbaud E, et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse. Blood. 1992;79:2578-2582.
2. Clift RA, Buckner CD, Thomas ED, et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood. 1994;84:2036-2043.
3. Ringden O, Ruutu T, Remberger M, et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood. 1994;83:2723-2730.
4. Devergie A, Blaise D, Attal M, et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfancytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM). Blood. 1995;85:2263-2268.
5. Childs R, Epperson D, Bahceci E, Clave E, Barrett J. Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect. Br J Haematol. 1999;107:396-400.
6. Ringden O, Labopin M, Tura S, et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia: Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol. 1996;93:637-645.
7. Michel G, Gluckman E, Esperou-Bourdeau H, et al. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation: a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol. 1994;12: 1217-1222.
8. Socié G, Clift R, Blaise D, et al. Busulfan (BU)-cyclophosphamide (Cy) versus Cy-total body irradiation as conditioning regimen before bone marrow transplantation (BMT) for acute myelogenous leukemia (AML) or chronic myelogenous leukemia (CML): long-term follow-up of 4 randomized trials [abstract]. Blood. 2000;96:557a.